郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.

期刊：Neuroscience发表年份：2005作者：H S Ahn; J-S Choi; B H Choi; M-J Kim; D-J Rhie; S-H Yoon; Y-H Jo; M-S Kim; K-W Sung; S J Hahn
阅读更多 →

药效评价Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.

期刊：Pharmacogenetics and genomics发表年份：2005作者：Danxin Wang; Andrew D Johnson; Audrey C Papp; Deanna L Kroetz; Wolfgang Sadée
阅读更多 →

药效评价The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

期刊：Psychopharmacology发表年份：2005作者：Marilyn A Davies; Beth Ann Compton-Toth; Sandra J Hufeisen; Herbert Y Meltzer; Bryan L Roth
阅读更多 →

药效评价Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.

期刊：Journal of medicinal chemistry发表年份：2005作者：Giulio G Muccioli; Diana Martin; Gerhard K E Scriba; Wolfgang Poppitz; Jacques H Poupaert; Johan Wouters; Didier M Lambert
阅读更多 →